We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISPR icon
2576
Ispire Technology
ISPR
$86.7M
-9
Closed -$56
ITGR icon
2577
Integer Holdings
ITGR
$4.23B
-5
Closed -$650
ITOS
2578
DELISTED
iTeos Therapeutics
ITOS
-95
Closed -$970
IUSB icon
2579
iShares Core Universal USD Bond ETF
IUSB
$43.1B
-1,544
Closed -$72.8K
IVT icon
2580
InvenTrust Properties
IVT
$2.67B
-30
Closed -$852
IWR icon
2581
iShares Russell Mid-Cap ETF
IWR
$57.2B
-180
Closed -$15.9K
JAMF
2582
DELISTED
Jamf
JAMF
-1,137
Closed -$19.7K
JBI icon
2583
Janus International
JBI
$768M
-547
Closed -$5.53K
JILL icon
2584
J. Jill
JILL
$285M
-11
Closed -$272
JRVR icon
2585
James River Group Holdings
JRVR
$215M
-3,916
Closed -$24.6K
JYNT icon
2586
The Joint Corp
JYNT
$118M
-27
Closed -$309
KE
2587
Kimball Electronics
KE
$654M
-17
Closed -$315
KLTR icon
2588
Kaltura
KLTR
$217M
-258
Closed -$351
KODK icon
2589
Kodak
KODK
$894M
-473
Closed -$2.23K
KPTI icon
2590
Karyopharm Therapeutics
KPTI
$46.5M
-36
Closed -$447
KROS icon
2591
Keros Therapeutics
KROS
$199M
-16
Closed -$930
KRYS icon
2592
Krystal Biotech
KRYS
$9.44B
-6
Closed -$1.09K
KURA icon
2593
Kura Oncology
KURA
$839M
-26
Closed -$509
KYN icon
2594
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
-115
Closed -$1.26K
LCID icon
2595
Lucid Motors
LCID
$3.02B
-23
Closed -$802
LE icon
2596
Lands' End
LE
$397M
-21
Closed -$363
LEGH icon
2597
Legacy Housing
LEGH
$654M
-25
Closed -$684
LESL icon
2598
Leslie's
LESL
$12.4M
-5
Closed -$342
LEVI icon
2599
Levi Strauss
LEVI
$9.52B
-4
Closed -$88
LIND icon
2600
Lindblad Expeditions
LIND
$2.19B
-260
Closed -$2.4K

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.